Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Albanell

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Medicina Clinica|February 10, 1990
[Treatment with interferon of systemic Langerhans-cell histiocytosis in an adult]J Albanell, A Salud, J Bellmunt, et al.
Cancer|November 20, 1997
Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinomaJ Bellmunt, A Ribas, N Eres, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcomaM Engelhardt, J Albanell, P Drullinsky, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
Frequent dose delays and growth factor requirements with the sequential doxorubicin-CMF scheduleA Ribas, J Albanell, J Bellmunt, et al.
Cancer|March 5, 1998
Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinomaA Ribas, J Albanell, L A Solé-Calvo, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1995
Malignant lymphoproliferative diseases in HIV-seropositive patients. A study of 40 cases at a single institution in SpainA Ribas, J Bellmunt, J Albanell, et al.
British Journal of Cancer|May 6, 2008
Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation studyA Awada, J Albanell, P A Canney, et al.
Journal of the National Cancer Institute|November 15, 1997
High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stageJ Albanell, F Lonardo, V Rusch, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 30, 2014
Subcutaneous trastuzumab: drug development and current positionP Martín Martorell, B Bermejo de Las Heras, J A Pérez-Fidalgo, et al.
Cancer|October 1, 1992
Carboplatin, methotrexate, and vinblastine in patients with bladder cancer who were ineligible for cisplatin-based chemotherapyJ Bellmunt, J Albanell, O S Gallego, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Medicina Clinica|February 10, 1990
[Treatment with interferon of systemic Langerhans-cell histiocytosis in an adult]J Albanell, A Salud, J Bellmunt, et al.
Cancer|November 20, 1997
Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinomaJ Bellmunt, A Ribas, N Eres, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcomaM Engelhardt, J Albanell, P Drullinsky, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
Frequent dose delays and growth factor requirements with the sequential doxorubicin-CMF scheduleA Ribas, J Albanell, J Bellmunt, et al.
Cancer|March 5, 1998
Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinomaA Ribas, J Albanell, L A Solé-Calvo, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1995
Malignant lymphoproliferative diseases in HIV-seropositive patients. A study of 40 cases at a single institution in SpainA Ribas, J Bellmunt, J Albanell, et al.
British Journal of Cancer|May 6, 2008
Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation studyA Awada, J Albanell, P A Canney, et al.
Journal of the National Cancer Institute|November 15, 1997
High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stageJ Albanell, F Lonardo, V Rusch, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 30, 2014
Subcutaneous trastuzumab: drug development and current positionP Martín Martorell, B Bermejo de Las Heras, J A Pérez-Fidalgo, et al.
Cancer|October 1, 1992
Carboplatin, methotrexate, and vinblastine in patients with bladder cancer who were ineligible for cisplatin-based chemotherapyJ Bellmunt, J Albanell, O S Gallego, et al.
Pageof 10